Do you know anything about LGL?
June 3
You're absolutely right, and that frustration is completely valid. CMML as a whole is rare — only around 1,100 people are diagnosed in the U.S. each year — so information specifically about CMML-2 can feel like searching for a needle in a very small haystack.
CMML is classified into three subtypes based on the percentage Show Full Answer
You're absolutely right, and that frustration is completely valid. CMML as a whole is rare — only around 1,100 people are diagnosed in the U.S. each year — so information specifically about CMML-2 can feel like searching for a needle in a very small haystack.
CMML is classified into three subtypes based on the percentage of blast cells (immature cells) found in the blood and bone marrow:
- CMML-0 — Less than 2% blasts in blood, less than 5% in bone marrow
- CMML-1 — 2%–4% blasts in blood, 5%–9% in bone marrow
- CMML-2 — 5%–19% blasts in blood, 10%–19% in bone marrow CMML-2 represents a more advanced stage, with a higher blast cell count. This can influence both prognosis and treatment decisions. It's worth knowing that around 15%–30% of people with CMML can progress to a more acute form of leukemia, making close monitoring especially important.
Treatment options that may be discussed with your doctor include:
- Bone marrow transplant — considered for younger, healthier patients with more advanced disease
- Chemotherapy — to help normalize blood cell counts
- Supportive care — such as blood transfusions or growth factors to manage symptoms
- Clinical trials — an evolving area worth exploring with your care team
Always speak with your specialist about what's most appropriate for your specific situation.
June 3
Join
Your Privacy Choices
